Lastest from Businesswire

PARIS & LONDON--(BUSINESS WIRE)--Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to $1.5 billion including $1.1 billion cash upfront plus potential milestone payments. This marks Sofinnova Partners' seventh exit in three years. Myricx Bio is a UK-headquartered transatlantic biotech company focused on the discovery and development of a novel class o

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best will sponsor and participate at the Vietnam Insurance Summit, to be held 31 July 2026, in Da Nang, Vietnam. Thuy Anh Ngo, market development manager, AM Best, will discuss the credit rating agency’s 2026 outlook on Vietnam’s non-life insurance segment. The presentation, which will include topics such as insurance demand, regulatory refinements and market competition, is scheduled for 2:00 p.m. ICT. Additionally, Rob Curtis, managing director and chief exe

BOSTON--(BUSINESS WIRE)--Access Advance announced additions to the VVC Advance Patent Pool, including Samsung Electronics and Sharp Corporation as Licensors and Licensees.

LOS ANGELES--(BUSINESS WIRE)---- $ON--ON Investors Have Opportunity to Join ON Semiconductor Corporation Fraud Investigation with the Schall Law Firm

BOSTON--(BUSINESS WIRE)--Kaname Capital (“Kaname” or “we”) today issued a public letter addressed to the Board of Directors, the Board of Corporate Auditors, and the Third-Party Committee of Fukuda Denshi Co., Ltd. (securities code: 6960; “Fukuda Denshi”). We give a measure of credit, as a sign of a commitment to governance reform, to the establishment of the Third-Party Committee announced on June 25, 2026 and to the launch of the governance reform project announced at the shareholders’ meetin